The safety profile of AOD-9604 is favorable compared to many metabolic interventions, with clinical trials involving approximately 900 participants demonstrating good tolerability and minimal side effects
In preclinical and in-vitro models, reta peptide (retatrutide, GLP3-R) is studied as a triple-receptor agonist reference compound targeting GLP-1R, GIPR, and GCGR
We, in abiding by the law make no claims of a miracle cure or permanent results
5 Understanding Non-Celiac Gluten Sensitivity Some people who do not have celiac disease or a wheat or gluten allergy may still experience symptoms in response to gluten ingestion
Many patients ask whether they should stay on GLP-1s indefinitely or consider bariatric surgery if they want lasting results
Heskamp S, Boerman OC, Molkenboer-Kuenen JD, Wauters CA, Strobbe LJ, Mandigers CM, et al